Cobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021 To download click here Friday 2 October 2020 11:00 Categories: Covid-19 News Year - 2020 Previous Post << >> Next Post